ClinConnect ClinConnect Logo
Search / Trial NCT06493097

Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study

Launched by KAROLINSKA INSTITUTET · Jul 2, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment option called hypnotherapy, delivered through audio files, for children and adolescents in Sweden who have certain gut-related issues, like irritable bowel syndrome or functional abdominal pain. The goal is to see if this method is effective and practical for helping these young patients manage their symptoms. The researchers have tailored the treatment to suit Swedish families, building on previous studies done in the Netherlands. If successful, this approach could make it easier for more children to access effective treatments without needing to meet with a psychologist in person.

To be eligible for the study, participants should be aged between 2 to 18 years and diagnosed with specific gastrointestinal disorders. They also need to understand Swedish, and at least one parent must as well. The study is currently recruiting participants, and those involved can expect to use audio files for their hypnotherapy, which is a low-cost treatment option that could save families money and reduce wait times for care. Overall, this study hopes to provide new, effective treatment choices for children struggling with gut-brain interaction disorders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis: irritable bowel syndrome, functional abdominal pain, functional dyspepsia (following the Rome IV diagnostic criteria)
  • The participant and at least one of the parents must understand Swedish
  • Exclusion Criteria:
  • other medical condition that better explains the symtoms
  • Absence from school \>40% and/or psychiatric diagnosis that is judged to be more primary than the gastrointestinal problems, in these cases the children/young people are judged to need more intensive and multi-professional treatment

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Ola Olén, MD PhD prof

Principal Investigator

Department of clinical epidemiology, Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported